Decreased expression of proapoptotic genes caspase-8- and BCL2-associated agonist of cell death (BAD) in ovarian cancer

Clinical Ovarian and other Gynecologic Cancer

Volumn 7, Issue 1-2, 2014, Pages 18-23

  Borhani, Nasim ^a,b   Manoochehri, Mehdi ^c   Saleh Gargari, Soraya ^d   Ghaffari Novin, Marefat ^a   Mansouri, Ardalan ^a   Omrani, Mir Davood ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHROUD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Apoptosis; BAD gene; Caspase 8; DNA methylation; Ovarian cancer

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 8; PROTEIN BAD; PROTEIN BAK; PROTEIN BAX; PROTEIN BID;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CLINICAL ARTICLE; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; OVARY CANCER; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84926407464     PISSN: 22129553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cogc.2014.12.004     Document Type: Article

References (36)

1. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA Cancer J Clin 60 2010 Sep-Oct 277 300
2. G. Chornokur, E.K. Amankwah, J.M. Schildkraut, and C.M. Phelan Global ovarian cancer health disparities Gynecol Oncol 129 2013 Apr 258 264
3. D. Cvetkovic Early events in ovarian oncogenesis Reprod Biol Endocrinol 1 2003 Oct 7 68
4. D. Badgwell, and R.C. Bast Jr. Early detection of ovarian cancer Dis Markers 23 2007 397 410
5. R. Etzioni, N. Urban, and S. Ramsey The case for early detection Nat Rev Cancer 3 2003 Apr 243 252
6. H. Matsushita, K. Watanabe, T. Yokoi, and A. Wakatsuki Unexpected ovarian malignancy following laparoscopic excision of adnexal masses Hum Reprod 2014 deu162
7. G. Bogani, A. Cromi, and S. Uccella Laparoscopic versus vaginal hysterectomy for benign indications in women aged 65 years or older: propensity-matched analysis Menopause 2014
8. C.A. Barton, N.F. Hacker, S.J. Clark, and P.M. O'Brien DNA methylation changes in ovarian cancer: implications for early diagnosis, prognosis and treatment Gynecol Oncol 109 2008 Apr 129 139
9. S. Kang, S.M. Dong, and N.H. Park Frequent promoter hypermethylation of TGFBI in epithelial ovarian cancer Gynecol Oncol 118 2010 Jul 58 63
10. M. Campan, M. Moffitt, and S. Houshdaran Genome-scale screen for DNA methylation-based detection markers for ovarian cancer PLoS One 6 2011 e28141
11. C.M. Ho, C.J. Huang, C.Y. Huang, Y.Y. Wu, S.F. Chang, and W.F. Cheng Promoter methylation status of HIN-1 associated with outcomes of ovarian clear cell adenocarcinoma Mol Cancer 11 2012 53
12. Y. Gao, G. Lou, and G.M. Zhang CHFR promoter hypermethylation and reduced CHFR mRNA expression in ovarian cancer Int J Biol Markers 24 2009 Apr-Jun 83 89
13. M.J. Socha, N. Said, and Y. Dai Aberrant promoter methylation of SPARC in ovarian cancer Neoplasia 11 2009 Feb 126 135
14. A. Czekierdowski, S. Czekierdowska, and J. Danilos Microvessel density and CpG island methylation of the THBS2 gene in malignant ovarian tumors J Physiol Pharmacol 59 Suppl 4 2008 Sep 53 65
15. Y.L. Choi, S.Y. Kang, and Y.K. Shin Aberrant hypermethylation of RASSF1A promoter in ovarian borderline tumors and carcinomas Virchows Arch 448 2006 Mar 331 336
16. L. Ouyang, Z. Shi, and S. Zhao Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis Cell Prolif 45 2012 Dec 487 498
17. F.H. Igney, and P.H. Krammer Death and anti-death: tumour resistance to apoptosis Nat Rev Cancer 2 2002 Apr 277 288
18. A. Portela, and M. Esteller Epigenetic modifications and human disease Nat Biotechnol 28 2010 Oct 1057 1068
19. E.C. de Bruin, and J.P. Medema Apoptosis and non-apoptotic deaths in cancer development and treatment response Cancer Treat Rev 34 2008 Dec 737 749
20. N. Huang, J. Zhu, and D. Liu Overexpression of Bcl-2-Associated Death Inhibits A549 Cell Growth In Vitro and In Vivo Cancer Biother Radiopharm 27 2012 164 168
21. N. Huang, J. Zhu, and D. Liu Overexpression of Bcl-2-associated death inhibits A549 cell growth in vitro and in vivo Cancer Biother Radiopharm 27 2012 Mar 164 168
22. Y. Huang, D. Liu, and B. Chen Loss of Bad expression confers poor prognosis in non-small cell lung cancer Med Oncol 29 2012 Sep 1648 1655
23. Y. Tan, M.R. Demeter, H. Ruan, and M.J. Comb BAD Ser-155 phosphorylation regulates BAD/Bcl-XL interaction and cell survival J Biol Chem 275 2000 Aug 18 25865 25869
24. E.W. Duiker, A.G. van der Zee, and P. de Graeff The extrinsic apoptosis pathway and its prognostic impact in ovarian cancer Gynecol Oncol 116 2010 Mar 549 555
25. S. Fulda Caspase-8 in cancer biology and therapy Cancer Lett 281 2009 Aug 28 128 133
26. Q.B. She, D.B. Solit, Q. Ye, K.E. O'Reilly, J. Lobo, and N. Rosen The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells Cancer Cell 8 2005 Oct 287 297
27. N.J. Yoo, J.W. Lee, and E.G. Jeong Expressional analysis of anti-apoptotic phospho-BAD protein and mutational analysis of pro-apoptotic BAD gene in hepatocellular carcinomas Dig Liver Dis 38 2006 Sep 683 687
28. E.W. Duiker, A. Meijer, and A.R. van der Bilt Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis Br J Cancer 104 2011 Apr 12 1278 1287
29. C.M. Van Geelen, B. Pennarun, and W.B. Ek Downregulation of active caspase 8 as a mechanism of acquired TRAIL resistance in mismatch repair-proficient colon carcinoma cell lines Int J Oncol 37 2010 Oct 1031 1041
30. F. Ozdemir, J. Altinisik, A. Karateke, H. Coksuer, and N. Buyru Methylation of tumor suppressor genes in ovarian cancer Exp Ther Med 4 2012 Dec 1092 1096
31. C. Pompeia, D.R. Hodge, and C. Plass Microarray analysis of epigenetic silencing of gene expression in the KAS-6/1 multiple myeloma cell line Cancer Res 64 2004 May 15 3465 3473
32. K. Malekzadeh, R.C. Sobti, and M. Nikbakht Methylation patterns of Rb1 and Casp-8 promoters and their impact on their expression in bladder cancer Cancer Invest 27 2009 Jan 70 80
33. M.J. Bello, J.M. De Campos, A. Isla, C. Casartelli, and J.A. Rey Promoter CpG methylation of multiple genes in pituitary adenomas: frequent involvement of caspase-8 Oncol Rep 15 2006 Feb 443 448
34. P. Gonzalez-Gomez, M.J. Bello, and M.M. Inda Deletion and aberrant CpG island methylation of Caspase 8 gene in medulloblastoma Oncol Rep 12 2004 Sep 663 666
35. N. Shivapurkar, S. Toyooka, and M.T. Eby Differential inactivation of caspase-8 in lung cancers Cancer Biol Ther 1 2002 Jan-Feb 65 69
36. H.J. Yang, V.W. Liu, Y. Wang, P.C. Tsang, and H.Y. Ngan Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data BMC Cancer 6 2006 212